Kwarlay.com

Navigating the News Maze with Clarity

    • Medicine

    FDA Accepts Resubmission of Supplemental Biologics License Application for Dupixent for Chronic Spontaneous Urticaria in Patients Under 12

    admin Posted on

    The resubmission for Dupixent includes new data in pediatric patients with chronic spontaneous urticaria.

    LEAVE A RESPONSE

    Your email address will not be published. Required fields are marked *

    admin
    View all posts

    You Might Also Like

    Slot
    TOGEL ONLINE